HealthpointCapital
HealthpointCapital is a private equity firm exclusively focused on the Musculoskeletal Healthcare sector. The firm provides equity investments and active operational mentorship informed by sector-specific research and clinical expertise, aiming to accelerate growth and create value in musculoskeletal and orthopedic companies.
HealthpointCapital
New York, New York, United States, North America
Services
Private equity investments (majority stakes and acquisitions)
Provides capital via private equity transactions, including majority-stake acquisitions and platform investments in musculoskeletal healthcare companies.
Strategic guidance and active mentorship
Board-level and operational support, leadership mentoring, and performance acceleration for portfolio companies.
Clinical and scientific advisory support
Access to musculoskeletal scientific and clinical advisors who support sourcing, clinical assessment, and qualification of technologies and services.
Research-driven sourcing and diligence
Research-informed deal sourcing and investment decision-making; extensive sector research informs every decision.
Exit and strategic acquirer relationships
Maintains relationships with strategic acquirers at the CEO level to support exit planning and transactions.
Consulting services (ad hoc)
May provide consulting services to companies mentioned or to portfolio companies, per firm disclosure.
Private equity investments (majority stakes and acquisitions)
Provides capital via private equity transactions, including majority-stake acquisitions and platform investments in musculoskeletal healthcare companies.
Strategic guidance and active mentorship
Board-level and operational support, leadership mentoring, and performance acceleration for portfolio companies.
Clinical and scientific advisory support
Access to musculoskeletal scientific and clinical advisors who support sourcing, clinical assessment, and qualification of technologies and services.
Research-driven sourcing and diligence
Research-informed deal sourcing and investment decision-making; extensive sector research informs every decision.
Exit and strategic acquirer relationships
Maintains relationships with strategic acquirers at the CEO level to support exit planning and transactions.
Consulting services (ad hoc)
May provide consulting services to companies mentioned or to portfolio companies, per firm disclosure.
Portfolio
HealthpointCapital acquired a majority stake in CrossRoads (announced May 14, 2019) and CrossRoads was later sold to DePuy Synthes (announced February 10, 2022).
#Orthopedic extremities / Musculoskeletal healthcare
IlluminOss received 510(k) clearance for a new light console (Jan 31, 2024) and reported 10,000 light-cured implants used by surgeons (Jan 24, 2024).
#Musculoskeletal implants / orthopedic devices
HealthpointCapital announced acquisition of SteriCUBE, described as a multi-tray sterilization platform (April 10, 2024).
#Sterilization platform for medical devices (healthcare support technology)
HealthpointCapital acquired a majority stake in CrossRoads (announced May 14, 2019) and CrossRoads was later sold to DePuy Synthes (announced February 10, 2022).
#Orthopedic extremities / Musculoskeletal healthcare
IlluminOss received 510(k) clearance for a new light console (Jan 31, 2024) and reported 10,000 light-cured implants used by surgeons (Jan 24, 2024).
#Musculoskeletal implants / orthopedic devices
HealthpointCapital announced acquisition of SteriCUBE, described as a multi-tray sterilization platform (April 10, 2024).
#Sterilization platform for medical devices (healthcare support technology)